{"description":"All-Cause Mortality was reported for all randomized participants by treatment received. Six participants did not receive both treatments but were evaluated for all-cause mortality. Serious AEs and Other AEs were reported for all randomized participants who received at least 1 dose of study treatment. Per protocol, MedDRA preferred terms \"Neoplasm progression\", \"Malignant neoplasm progression\" and \"Disease progression\" not resulting in hospitalization or death were excluded as AEs.","eventGroups":[{"deathsNumAffected":10,"deathsNumAtRisk":141,"description":"In Treatment Crossover Period 1 participants first received pembrolizumab plus berahyaluronidase alfa SC for three 21-day cycles, followed by pembrolizumab IV for three 21-day cycles in Treatment Crossover Period 2. After completion of the Treatment Crossover Period, participants entered the Treatment Continuation Period where they received their preferred intervention for up to 17 21-day cycles (up to \\~1 year) for RCC and melanoma, and for up to 35 21-day cycles (up to \\~2 years) for NSCLC.","id":"EG000","otherNumAffected":99,"otherNumAtRisk":141,"seriousNumAffected":20,"seriousNumAtRisk":141,"title":"Pembrolizumab (+) Berahyaluronidase Alfa SC"},{"deathsNumAffected":6,"deathsNumAtRisk":141,"description":"In Treatment Crossover Period 1 participants first received pembrolizumab IV for three 21-day cycles, followed by pembrolizumab plus berahyaluronidase alfa SC for three 21-day cycles in Treatment Crossover Period 2. After completion of the Treatment Crossover Period, participants entered the Treatment Continuation Period where they received their preferred intervention for up to 17 21-day cycles (up to \\~1 year) for RCC and melanoma, and for up to 35 21-day cycles (up to \\~2 years) for NSCLC.","id":"EG001","otherNumAffected":63,"otherNumAtRisk":141,"seriousNumAffected":22,"seriousNumAtRisk":141,"title":"Pembrolizumab IV"}],"frequencyThreshold":"5","otherEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":141,"numEvents":12},{"groupId":"EG001","numAffected":8,"numAtRisk":141,"numEvents":8}],"term":"Anaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":20,"numAtRisk":141,"numEvents":20},{"groupId":"EG001","numAffected":14,"numAtRisk":141,"numEvents":16}],"term":"Hypothyroidism"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":21,"numAtRisk":141,"numEvents":26},{"groupId":"EG001","numAffected":6,"numAtRisk":141,"numEvents":8}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":141,"numEvents":14},{"groupId":"EG001","numAffected":7,"numAtRisk":141,"numEvents":9}],"term":"Asthenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":141,"numEvents":12},{"groupId":"EG001","numAffected":8,"numAtRisk":141,"numEvents":8}],"term":"Fatigue"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":141,"numEvents":10},{"groupId":"EG001","numAffected":0,"numAtRisk":141,"numEvents":0}],"term":"Injection site pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":141,"numEvents":15},{"groupId":"EG001","numAffected":0,"numAtRisk":141,"numEvents":0}],"term":"Injection site reaction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":141,"numEvents":8},{"groupId":"EG001","numAffected":5,"numAtRisk":141,"numEvents":5}],"term":"Upper respiratory tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":11,"numAtRisk":141,"numEvents":15},{"groupId":"EG001","numAffected":13,"numAtRisk":141,"numEvents":16}],"term":"Alanine aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":10,"numAtRisk":141,"numEvents":13},{"groupId":"EG001","numAffected":10,"numAtRisk":141,"numEvents":12}],"term":"Aspartate aminotransferase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":141,"numEvents":8},{"groupId":"EG001","numAffected":6,"numAtRisk":141,"numEvents":9}],"term":"Blood creatinine increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":7,"numAtRisk":141,"numEvents":9},{"groupId":"EG001","numAffected":8,"numAtRisk":141,"numEvents":8}],"term":"Hyperglycaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":141,"numEvents":13},{"groupId":"EG001","numAffected":5,"numAtRisk":141,"numEvents":5}],"term":"Arthralgia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":141,"numEvents":9},{"groupId":"EG001","numAffected":7,"numAtRisk":141,"numEvents":8}],"term":"Cough"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":20,"numAtRisk":141,"numEvents":24},{"groupId":"EG001","numAffected":9,"numAtRisk":141,"numEvents":9}],"term":"Pruritus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":12,"numAtRisk":141,"numEvents":14},{"groupId":"EG001","numAffected":4,"numAtRisk":141,"numEvents":4}],"term":"Rash"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":8,"numAtRisk":141,"numEvents":9},{"groupId":"EG001","numAffected":2,"numAtRisk":141,"numEvents":2}],"term":"Hypertension"}],"seriousEvents":[{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":141,"numEvents":0}],"term":"Acute myocardial infarction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Myocardial infarction"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Vertigo"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Adrenal insufficiency"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Endocrine disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":141,"numEvents":0}],"term":"Hypophysitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":2,"numAtRisk":141,"numEvents":2}],"term":"Diarrhoea"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Duodenal ulcer haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Gastritis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Stomatitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Upper gastrointestinal haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Asthenia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Death"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"General disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":141,"numEvents":0}],"term":"Systemic inflammatory response syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Bile duct stone"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Portal vein thrombosis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":141,"numEvents":0}],"term":"Abscess"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Diverticulitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Empyema"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":141,"numEvents":3},{"groupId":"EG001","numAffected":4,"numAtRisk":141,"numEvents":4}],"term":"Pneumonia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Urinary tract infection"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Urosepsis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Investigations","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":141,"numEvents":0}],"term":"Lipase increased"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":141,"numEvents":0}],"term":"Dehydration"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Hyperglycaemia"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Type 1 diabetes mellitus"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":141,"numEvents":0}],"term":"Back pain"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Facet joint syndrome"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":141,"numEvents":0}],"term":"Polymyalgia rheumatica"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":6,"numAtRisk":141,"numEvents":6},{"groupId":"EG001","numAffected":3,"numAtRisk":141,"numEvents":3}],"term":"Malignant neoplasm progression"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":141,"numEvents":0}],"term":"Ischaemic stroke"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":141,"numEvents":0}],"term":"Myasthenia gravis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Transient ischaemic attack"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":141,"numEvents":0}],"term":"Bipolar disorder"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Atelectasis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Chronic obstructive pulmonary disease"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Malignant pleural effusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":2,"numAtRisk":141,"numEvents":2}],"term":"Pleural effusion"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":141,"numEvents":0}],"term":"Pneumonitis"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":2,"numAtRisk":141,"numEvents":2}],"term":"Pulmonary embolism"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":141,"numEvents":1},{"groupId":"EG001","numAffected":0,"numAtRisk":141,"numEvents":0}],"term":"Pulmonary haemorrhage"},{"assessmentType":"SYSTEMATIC_ASSESSMENT","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 27.1","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":141,"numEvents":0},{"groupId":"EG001","numAffected":1,"numAtRisk":141,"numEvents":1}],"term":"Arteriosclerosis"}],"timeFrame":"Up to approximately 15 months"}